$MSB

MESABI TRUST

No enriched coverage for $MSB in the last 7 days.

No SEC Form 4 filings for $MSB in the last 30 days.

See all $MSB insider activity →

Mesabi Metallics chooses Midrex for Iowa mill DRI module

Nucor Plate Group will increase its fuel surcharge to $40 per short ton in November, citing rising costs. The company has doubled the surcharge in two consecutive months. Meanwhile, survey data shows mills are slightly more negotiable on sheet prices but less flexible on plate prices. US service centers' flat-rolled steel supply rose marginally in September, up 3.7% from August but still 15.5% below September 2025 levels.

Mesabi Trust Announcement of No Distribution

MESABI TRUST (MSB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ MESABI TRUST PRESS RELEASE October 15, 2026 @ 04:05 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE) Mesabi Trust Announcement of No Distribution The Trustees of Mesabi Trust (NYSE: MSB) have determined that no distribution has been declared this quarter, and no

MSB sentiment & insider activity

Recent MSB coverage spans earnings, corporate actions and financial news.

What's driving MSB

  • Midrex Technologies, a subsidiary of Kobe Steel, was selected by Mesabi Metallics to supply MIDREX Flex™ technology for a new steelmaking complex in Iowa, U.S., with a planned capacity of 10 million tons.

    marketscreener.com · Oct 19, 2026

  • Nucor Plate Group will increase its fuel surcharge to $40 per short ton in November, citing rising costs. The company has doubled the surcharge in two consecutive months. Meanwhile, survey data shows mills are slightly more negotiable on sheet prices but less flexible on plate prices. US service centers' flat-rolled steel supply rose marginally in September, up 3.7% from August but still 15.5% below September 2025 levels.

    steelmarketupdate.com · Oct 16, 2026

  • No distribution likely pressures the unit price as investors lose expected cash flow.

    SEC EDGAR 8-K · Oct 15, 2026

  • No distribution declaration signals weaker royalty cash flow, likely pressuring near-term unit-holder expectations and distribution-linked valuation.

    tradingview.com · Oct 15, 2026

  • Revenue decline and loss suggest downward pressure on MSB price.

    tradingview.com · Sep 11, 2026

AlphAI scores every news story that mentions MSB with an AI model for sentiment and relevance, and aggregates insider trades from MESABI TRUST's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MSB

Score

Mesabi Metallics chooses Midrex for Iowa mill DRI module

Nucor Plate Group will increase its fuel surcharge to $40 per short ton in November, citing rising costs. The company has doubled the surcharge in two consecutive months. Meanwhile, survey data shows mills are slightly more negotiable on sheet prices but less flexible on plate prices. US service centers' flat-rolled steel supply rose marginally in September, up 3.7% from August but still 15.5% below September 2025 levels.

$MSBLow

Mesabi Trust Announcement of No Distribution

MESABI TRUST (MSB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ MESABI TRUST PRESS RELEASE October 15, 2026 @ 04:05 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE) Mesabi Trust Announcement of No Distribution The Trustees of Mesabi Trust (NYSE: MSB) have determined that no distribution has been declared this quarter, and no

Mesabi Trust (MSB) Declares No November 2026 Distribution

Mesabi Trust (MSB) announced no distribution for the current quarter, down from $0.34 per unit a year ago. The trust cited lower July 2026 royalties of $1.81M, with no bonus royalty and increased reserve needs. The decline is attributed to weaker royalty receipts and the absence of bonus royalties from Cleveland-Cliffs/Northshore.

$MSBLow

Bonus royalties vanish as Mesabi Trust (NYSE: MSB) faces higher legal costs

Mesabi Trust (MSB) reported a Q2 net loss of $95,013, down from $4.74M a year earlier, due to lower royalty income and higher legal costs. Royalty income fell to $2.33M from $5.42M, with bonus royalties dropping to zero. The Trust cut its distribution to $0.05 per unit. Legal expenses increased due to ongoing arbitration with Northshore Mining and Cleveland-Cliffs. Pellet volumes rose slightly, but lower prices impacted royalties.

$TMCRHighAI 9/10

The Metals Royalty Company Announces Fully Allocated US$165 Million Financing to Fund Acquisition of Additional 1.0% Mesabi Royalty

The Metals Royalty Company (TMCR) announced a US$165 million financing package, including a US$140 million convertible note offering and a US$25 million term loan, to fund the acquisition of an additional 1.0% royalty in the Mesabi iron ore project and repay existing debt. The transactions are expected to close on August 24, 2026, subject to conditions. The notes have an 8.00% coupon and a five-year maturity, while the loan has a 24-month term with a 12-month extension option.

First Vietnamese bank surpasses $762mn in quarterly net interest income

Vietnam’s listed banks reported higher second-quarter 2026 net interest income versus the prior quarter, with only five banks declining. VietinBank led with a record VND20.7 trillion, first above VND20 trillion. BIDV, Vietcombank and VPBank also posted strong results. State Bank of Vietnam said system credit rose 8.38% to VND20.15 quadrillion by July 29.

$MSBLow

MESABI TRUST (MSB): Results of Operations and Financial Condition

MESABI TRUST (MSB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Item 2.02 Results of Operations and Financial Condition. Announcement of Receipt of Quarterly Royalty Report and Royalty Payment On July 30, 2026, Mesabi Trust received the quarterly royalty report of iron ore shipments out of Silver Bay, Minnesota during the quarter ended June 3

$MSBMed

Mesoblast Shares Break Resistance Following Latest Milestone

Mesoblast (ASX: MSB) shares rose after the company said its Phase 3 MSB-DR004 trial for rexlemestrocel-L in chronic lower back pain reached its target of at least 300 treated patients. The randomized, placebo-controlled study compares an intradiscal injection vs sham and follows patients for 12 months. The update removes an execution risk and supports a regulatory catalyst timeline.

Related tickers